N,N-Diethyl-2-propanamine → (S)-1-(3-fluorophenyl)-N-(1-(imidazo[1,2-a]pyrazin-8-yl)pyrrolidin-3-yl)-1H-1,2,4-triazole-3-carboxamide

HRID 1755270Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1755270
Cl.[N:2]1[CH:3]=[CH:4][N:5]2[CH:10]=[CH:9][N:8]=[C:7]([N:11]3[CH2:15][CH2:14][C@H:13]([NH2:16])[CH2:12]3)[C:6]=12.[F:17][C:18]1[CH:19]=[C:20]([N:24]2[CH:28]=[N:27][C:26]([C:29](O)=[O:30])=[N:25]2)[CH:21]=[CH:22][CH:23]=1.C(N(CC)C(C)C)C.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>CN(C=O)C.C(OCC)(=O)C>[F:17][C:18]1[CH:19]=[C:20]([N:24]2[CH:28]=[N:27][C:26]([C:29]([NH:16][C@H:13]3[CH2:14][CH2:15][N:11]([C:7]4[C:6]5[N:5]([CH:4]=[CH:3][N:2]=5)[CH:10]=[CH:9][N:8]=4)[CH2:12]3)=[O:30])=[N:25]2)[CH:21]=[CH:22][CH:23]=1

Komponenten

7

Versuchsvorschrift

To a suspension of (S)-1-(imidazo[1,2-a]pyrazin-8-yl)pyrrolidin-3-amine hydrochloride salt (84 mg, 0.3 mmol) and 1-(3-fluorophenyl)-1H-1,2,4-triazole-3-carboxylic acid (63 mg, 0.3 mmol) in DMF (5 mL) was added diethylisopropyl amine (650 mg, 5 mmol), followed by HATU (120 mg, 0.31 mmol). The resulting solution was stirred at room temperature for 1 h. The reaction mixture was diluted with ethyl acetate and washed with saturated aqueous solutions of KH2PO4 and NaHCO3, followed by brine. The organic layer was concentrated in vacuo and the residue purified by reverse phase HPLC (acetonitrile-H2O with 0.1% TFA as eluent) to give 88 mg of the title compound (75% yield) as a white solid.

Aufarbeitung

  1. washwashed with saturated aqueous solutions of KH2PO4 and NaHCO3
  2. concentrationThe organic layer was concentrated in vacuo
  3. customthe residue purified by reverse phase HPLC (acetonitrile-H2O with 0.1% TFA as eluent)

Quellen und Nachweise

ORD-Eintrag
ord-1b7506809213495d8c48cf13ee41a72c
Quelldatensatz
uspto-grants-2015_10
Patentnummer
US09169261B2

Notizen zur Reaktion

Wird geladen…